Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Armata Pharmaceuticals, Inc. | armp-20191231x10k.htm |
| EX-32.2 - EX-32.2 - Armata Pharmaceuticals, Inc. | armp-20191231ex322100132.htm |
| EX-32.1 - EX-32.1 - Armata Pharmaceuticals, Inc. | armp-20191231ex321571fe7.htm |
| EX-31.2 - EX-31.2 - Armata Pharmaceuticals, Inc. | armp-20191231ex312a2b8a0.htm |
| EX-31.1 - EX-31.1 - Armata Pharmaceuticals, Inc. | armp-20191231ex311630d74.htm |
| EX-23.1 - EX-23.1 - Armata Pharmaceuticals, Inc. | armp-20191231ex23166d6b1.htm |
| EX-4.8 - EX-4.8 - Armata Pharmaceuticals, Inc. | armp-20191231ex48d6b9585.htm |
Exhibit 21.1
Subsidiaries of Armata Pharmaceuticals, Inc.
The following companies are direct or indirect wholly owned subsidiaries of Armata Pharmaceuticals, Inc.:
|
Name |
|
Jurisdiction |
|
C3J Therapeutics, Inc. C3 Jian, LLC |
|
United States United States |
|
Biocontrol Limited |
|
United Kingdom |
|
AmpliPhi Australia Pty Ltd |
|
Australia |
|
Special Phage Holdings Pty Ltd |
|
Australia |
|
Special Phage Services Pty Ltd |
|
Australia |